NAV
₹21.7900
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +20.39%
- 3Y
- —
- 5Y
- —
- Since Inception
- +31.78%
SIP returns (XIRR)
- 1Y
- +37.05%
- 3Y
- —
- 5Y
- —
- Since Inception
- +27.33%
Performance Comparison
Thinking about HDFC Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseHDFC Mutual Fund
CategorySectoral / Thematic
Launch Date04 Oct 2023
AMFI Code152082
Transaction facts
Min. Lumpsum₹100
Min. SIP₹100
Exit LoadIn respect of each purchase switch in of units an Exit load of 1% is payable if units are redeemed switched out within 30 days from the date of allotment No Exit Load is payable if units are redeemed switched out after 30 days from the date of allotment
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 30 Jun 2026
portfolio shared with HDFC Pharma and Healthcare Fund - Growth Option
Holding% NAV
- 1Sun Pharmaceutical Industries Ltd.9.96%
- 2Divis Laboratories Ltd.7.16%
- 3Max Healthcare Institute Limited5.57%
- 4Lupin Ltd.5.26%
- 5Cipla Ltd.5.19%
- 6Aster Dm Healthcare Limited5.05%
- 7Acutaas Chemicals Limited4.58%
- 8Alkem Laboratories Ltd.4.00%
- 9Anthem Biosciences Limited3.81%
- 10Ipca Laboratories Ltd.3.53%
Rows per page· 35 total
Page 1/4
Investment Objective
HDFC Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
HDFC Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by HDFC Mutual Fund. The fund has been operational for over 2 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations